Dr. Joseph E. Eid, Who Led Merck's Pioneering Clinical Development of KEYTRUDA®, joins Dragonfly Therapeutics as President of R&D

/PRNewswire/ -- Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced that Joseph E. Eid,...

Related Keywords

Beirut ,Beyrouth ,Lebanon ,Josephe Eid ,Anne Deconinck ,Prnewswire Dragonfly Therapeutics Inc ,Joseph University School Of Medicine ,Rutgers Robert Wood Johnson Medical School ,Head Of Global Medical Affairs ,Therapeutics Inc ,Oncology Clinical Research At Roche Pharmacuticals ,Laboratory Medicine ,Bristol Myers Squibb ,Bill Haney ,Medical Oncology ,Senior Vice President ,Global Medical Affairs ,Oncology Clinical Research ,Joseph University School ,Assistant Professor ,Dragonfly Therapeutics ,Nc ,